Relapsing fever medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
Antimicrobial therapy for relapsing fever in adults depends on the vector (Tick-borne vs. Louse-borne) and includes either [[Doxycycline]], [[Erythromycin]], or [[Tetracyclines]]. Intravenous [[Ceftriaxone]] is added if either [[meningitis]] or [[encephalitis]] is present.
[[Antimicrobial]] therapy for [[relapsing fever]] in adults depends on the [[vector]] ([[Tick-borne relapsing fever|Tick-borne]] vs. [[Louse-borne relapsing fever|Louse-borne]]) and includes either [[Doxycycline]], [[Erythromycin]], or [[Tetracyclines]]. Intravenous [[Ceftriaxone]] is added if either [[meningitis]] or [[encephalitis]] is present.


==Medical Therapy==
==Medical Therapy==

Revision as of 01:39, 25 September 2020

Relapsing fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Relapsing fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Relapsing fever medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Relapsing fever medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Relapsing fever medical therapy

CDC on Relapsing fever medical therapy

Relapsing fever medical therapy in the news

Blogs on Relapsing fever medical therapy

Directions to Hospitals Treating Relapsing fever

Risk calculators and risk factors for Relapsing fever medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2]

Overview

Antimicrobial therapy for relapsing fever in adults depends on the vector (Tick-borne vs. Louse-borne) and includes either Doxycycline, Erythromycin, or Tetracyclines. Intravenous Ceftriaxone is added if either meningitis or encephalitis is present.

Medical Therapy

Erythromycin, Tetracyclines, Chloramphenicol, or Penicillins have all been shown to be effective for treating tick-borne relapsing fever (TBRF). Although the duration of therapy has not been well studied for TBRF, the current recommendation is seven days of antibiotic therapy. In contrast, louse-borne relapsing fever (LBRF) caused by B. recurrentis can be treated with a single dose of antibiotics.

For young children and pregnant women either Erythromycin and/or Penicillin are recommended for the treatment of TBRF.

When initiating antibiotic therapy, a patient should be watched closely for a Jarisch-Herxheimer reaction for the first 4 hours after the antibiotic is given. The reaction may be difficult to distinguish from a febrile crisis, with rigors and decreased blood pressure. Cooling blankets and appropriate use of antipyretic agents may be indicated and may be lessened by giving acetaminophen 650 mg orally 2 hours before and 2 hours after the first dose of antibiotic therapy. This reaction tends to be more severe in patients with louse-borne relapsing fever treated with penicillin.

Antimicrobial regimen

  • 1. Tick-Borne Relapsing Fever [1]
  • Preferred regimen: Doxycycline 100 mg PO bid for 5-10 days
  • Alternative regimen: Erythromycin 500 mg PO qid for 5-10 days
  • Note: If meningitis/encephalitis present, use Ceftriaxone 2 g IV q12h for 14 days
  • 2. Louse-Borne Relapsing Fever

References

  1. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.